Global Human Oocyte Cryopreservation Market Growth (Status and Outlook) 2025-2031

Global Human Oocyte Cryopreservation Market Growth (Status and Outlook) 2025-2031

The global Human Oocyte Cryopreservation market size is predicted to grow from US$ 89 million in 2025 to US$ 212 million in 2031; it is expected to grow at a CAGR of 15.6% from 2025 to 2031.

Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.

Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196°C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.

The driving factors of the oocyte cryopreservation market mainly include the following aspects:

Technological progress

The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.

Changes in fertility concepts

The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.

Growth in medical demand

With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.

Policy support

The support policies of some countries and regions for assisted reproductive technology, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.

Unlike sperm, oocytes are larger and contain a lot of water, which makes it easier to form ice crystals that may damage the eggs during the freezing process. In addition, egg extraction is not easy and the number is scarce, so the selection of protective agents during the freezing process is also more demanding. These factors have made egg freezing one of the difficulties in freezing technology.

However, with the continuous advancement of technology, the success rate of oocyte cryopreservation has been significantly improved. International clinical trials have proven that frozen eggs can be stored for at least ten years, and they still have the ability to conceive after thawing, can form healthy embryos, and can normally conceive babies. This has led more and more women to choose to preserve their future reproductive ability through oocyte cryopreservation technology, that is, to buy a "fertility insurance".

In general, oocyte cryopreservation technology provides an effective option for women who want to preserve their fertility, and also provides new possibilities for the development of assisted reproductive technology.

LPI (LP Information)' newest research report, the “Human Oocyte Cryopreservation Industry Forecast” looks at past sales and reviews total world Human Oocyte Cryopreservation sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Oocyte Cryopreservation sales for 2025 through 2031. With Human Oocyte Cryopreservation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Oocyte Cryopreservation industry.

This Insight Report provides a comprehensive analysis of the global Human Oocyte Cryopreservation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Oocyte Cryopreservation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Oocyte Cryopreservation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Oocyte Cryopreservation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Oocyte Cryopreservation.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Oocyte Cryopreservation market by product type, application, key players and key regions and countries.

Segmentation by Type:
Slow-cooling Method
Flash-freezing Process (Vitrification)

Segmentation by Application:
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility

Please note: The report will take approximately 2 business days to prepare and deliver.